Literature DB >> 26171186

Radiation-induced lower cranial nerve palsy in patients with head and neck carcinoma.

Stefan Janssen1, Christoph Glanzmann2, Bita Yousefi2, Karl Loewenich2, Gerhard Huber3, Stephan Schmid4, Gabriela Studer2.   

Abstract

Radiation-induced cranial nerve palsy (RICNP) is a severe long-term complication in patients with head and neck cancer following high-dose radiation therapy (RT). We present the case report of a patient with bilateral RICNP of the hypoglossal and vagus cranial nerves (XII/X) following postoperative RT in the era prior to the introduction of intensity-modulated RT (IMRT), and an analysis of our IMRT patient cohort at risk including the case of a XII RICNP. A total of 201 patients whose glosso-pharyngeal (IX), X and XII cranial nerves had been exposed to >65 Gy definitive IMRT in our institution between January, 2002 and December, 2012 with or without systemic therapy, were retrospectively identified. A total of 151 patients out of 201 fulfilling the following criteria were included in the analysis: Locoregionally controlled disease, with a follow-up (FU) of >24 months and >65 Gy exposure of the nerves of interest. So far, one of the assessed 151 IMRT patients at risk exhibited symptoms of RICNP after 6 years. The mean/median FU of the entire cohort was 71/68 months (range, 27-145). The results were compared with literature reports. In conclusion, RICNP appears to be a rare complication. However, a longer FU and a larger sample size are required to draw reliable conclusions on the incidence of RICNP in the era of IMRT.

Entities:  

Keywords:  intensity-modulated radiation therapy; lower cranial nerves; radiation tolerance; radiation-induced cranial nerve palsy

Year:  2015        PMID: 26171186      PMCID: PMC4487065          DOI: 10.3892/mco.2015.558

Source DB:  PubMed          Journal:  Mol Clin Oncol        ISSN: 2049-9450


  18 in total

1.  Simultaneous integrated boost intensity-modulated radiotherapy (SIB‑IMRT) in nasopharyngeal cancer.

Authors:  Evangelia Peponi; Christoph Glanzmann; Guntram Kunz; Christoph Renner; Katja Tomuschat; Gabriela Studer
Journal:  Strahlenther Onkol       Date:  2010-02-22       Impact factor: 3.621

2.  Intensity-modulated radiotherapy for nasopharyngeal carcinoma: clinical correlation of dose to the pharyngo-esophageal axis and dysphagia.

Authors:  Tsien F Fua; June Corry; Alvin D Milner; Jim Cramb; Sue F Walsham; Lester J Peters
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-01-17       Impact factor: 7.038

3.  Carcinoma of the nasopharynx treated by radiotherapy alone: determinants of local and regional control.

Authors:  G Sanguineti; F B Geara; A S Garden; S L Tucker; K K Ang; W H Morrison; L J Peters
Journal:  Int J Radiat Oncol Biol Phys       Date:  1997-03-15       Impact factor: 7.038

4.  Predictive factors and radiological features of radiation-induced cranial nerve palsy in patients with nasopharyngeal carcinoma following radical radiotherapy.

Authors:  Yiu S Luk; John S F Shum; Henry C K Sze; Lucy L K Chan; W T Ng; Anne W M Lee
Journal:  Oral Oncol       Date:  2012-08-11       Impact factor: 5.337

5.  Hypofractionated dose-painting intensity modulated radiation therapy with chemotherapy for nasopharyngeal carcinoma: a prospective trial.

Authors:  Richard L Bakst; Nancy Lee; David G Pfister; Michael J Zelefsky; Margie A Hunt; Dennis H Kraus; Suzanne L Wolden
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-06-03       Impact factor: 7.038

6.  Radiation-induced cranial nerve palsy: a cross-sectional study of nasopharyngeal cancer patients after definitive radiotherapy.

Authors:  Lin Kong; Jiade J Lu; Adam L Liss; Chaosu Hu; Xiaomao Guo; Yongru Wu; Youwang Zhang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-06-03       Impact factor: 7.038

7.  Hypoglossal nerve palsy in nasopharyngeal carcinoma.

Authors:  A D King; S F Leung; P Teo; W W Lam; Y L Chan; C Metreweli
Journal:  Head Neck       Date:  1999-10       Impact factor: 3.147

8.  Treatment outcome of patients with stages I-II nasopharyngeal carcinoma after late course accelerated hyperfractionation radiotherapy alone.

Authors:  Xiayun He; Ming Ye; Xiaomao Guo; Ziqiang Pan; Zhen Zhang; Shaoqin He; Taifu Liu
Journal:  Oral Oncol       Date:  2012-05-31       Impact factor: 5.337

9.  Is there a life-long risk of brachial plexopathy after radiotherapy of supraclavicular lymph nodes in breast cancer patients?

Authors:  Amira Bajrovic; Dirk Rades; Fabian Fehlauer; Silke Tribius; Ulrike Hoeller; Volker Rudat; Horst Jung; Winfried Alberti
Journal:  Radiother Oncol       Date:  2004-06       Impact factor: 6.280

10.  Late term tolerance in head neck cancer patients irradiated in the IMRT era.

Authors:  Gabriela Studer; Claudia Linsenmeier; Oliver Riesterer; Yousef Najafi; Michelle Brown; Bita Yousefi; Marius Bredell; Gerhard Huber; Stephan Schmid; Stephan Studer; Roger Zwahlen; Tamara Rordorf; Christoph Glanzmann
Journal:  Radiat Oncol       Date:  2013-11-05       Impact factor: 3.481

View more
  2 in total

Review 1.  Radiation-induced neuropathies in head and neck cancer: prevention and treatment modalities.

Authors:  Patrick Azzam; Manal Mroueh; Marina Francis; Alaa Abou Daher; Youssef H Zeidan
Journal:  Ecancermedicalscience       Date:  2020-11-03

2.  Differences in lower cranial nerve complications predicted by the NTCP model between RTOG and reduced-volume IMRT planning in radiotherapy for nasopharyngeal carcinoma.

Authors:  Jianjun Qian; Yongqiang Yang; Pengfei Xing; Cuihong Wang; Ye Tian; Xueguan Lu
Journal:  Transl Cancer Res       Date:  2020-01       Impact factor: 1.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.